These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17455658)

  • 21. Community-acquired pneumonia and bacteraemia in a healthy young woman caused by methicillin-resistant Staphylococcus aureus (MRSA) carrying the genes encoding Panton-Valentine leukocidin (PVL).
    Torell E; Molin D; Tano E; Ehrenborg C; Ryden C
    Scand J Infect Dis; 2005; 37(11-12):902-4. PubMed ID: 16308227
    [No Abstract]   [Full Text] [Related]  

  • 22. Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
    De Gascun C; Rajan L; O'Neill E; Smyth EG
    J Antimicrob Chemother; 2006 Jan; 57(1):150-1. PubMed ID: 16244085
    [No Abstract]   [Full Text] [Related]  

  • 23. How to prevent transmission of MRSA in the open community?
    Vandenesch F; Etienne J
    Euro Surveill; 2004 Nov; 9(11):5. PubMed ID: 15591694
    [No Abstract]   [Full Text] [Related]  

  • 24. Community-acquired methicillin-resistant Staphylococcus aureus infections.
    Maltezou HC; Giamarellou H
    Int J Antimicrob Agents; 2006 Feb; 27(2):87-96. PubMed ID: 16423509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus in Hokkaido, northern main island of Japan: identification of sequence types 6 and 59 Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus.
    Kawaguchiya M; Urushibara N; Kuwahara O; Ito M; Mise K; Kobayashi N
    Microb Drug Resist; 2011 Jun; 17(2):241-50. PubMed ID: 21395449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linezolid and clindamycin improve the outcome of severe, necrotizing pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).
    Soavi L; Signorini L; Stellini R; Acquarolo A; Fiorese B; Magri S; Pantosti A; Suter F; Carori G
    Infez Med; 2011 Mar; 19(1):42-4. PubMed ID: 21471746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models.
    LaPlante KL; Leonard SN; Andes DR; Craig WA; Rybak MJ
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2156-62. PubMed ID: 18411321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of MRSA endocarditis during linezolid treatment.
    Ben Mansour EH; Jacob E; Monchi M; Ledoux D; Canivet JL; De Mol P; Damas P
    Eur J Clin Microbiol Infect Dis; 2003 Jun; 22(6):372-3. PubMed ID: 12768433
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections.
    Ellis MW; Lewis JS
    Curr Opin Infect Dis; 2005 Dec; 18(6):496-501. PubMed ID: 16258322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Report on the first PVL-positive community acquired MRSA strain in Latvia.
    Miklasevics E; Haeggman S; Balode A; Sanchez B; Martinsons A; Olsson-Liljequist B; Dumpis U
    Euro Surveill; 2004 Nov; 9(11):29-30. PubMed ID: 15591692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers.
    Mendes RE; Sader HS; Deshpande L; Jones RN
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):433-6. PubMed ID: 18068326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How important is methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia and what is best antimicrobial therapy?
    Wunderink RG
    Infect Dis Clin North Am; 2013 Mar; 27(1):177-88. PubMed ID: 23398873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community-acquired MRSA infection: an update.
    Ragan P
    JAAPA; 2006 Apr; 19(4):24-9. PubMed ID: 16626103
    [No Abstract]   [Full Text] [Related]  

  • 34. Clones and drones: do variants of Panton-Valentine leukocidin extend the reach of community-associated methicillin-resistant Staphylococcus aureus?
    John JF; Lindsay JA
    J Infect Dis; 2008 Jan; 197(2):175-8. PubMed ID: 18177251
    [No Abstract]   [Full Text] [Related]  

  • 35. Polymorphism of the Staphylococcus aureus Panton-Valentine leukocidin genes and its possible link with the fitness of community-associated methicillin-resistant S. aureus.
    Dumitrescu O; Tristan A; Meugnier H; Bes M; Gouy M; Etienne J; Lina G; Vandenesch F
    J Infect Dis; 2008 Sep; 198(5):792-4. PubMed ID: 18694339
    [No Abstract]   [Full Text] [Related]  

  • 36. Emergence of Panton-Valentine leukocidin-positive ST59 methicillin-susceptible Staphylococcus aureus with high cytolytic peptide expression in association with community-acquired pediatric osteomyelitis complicated by pulmonary embolism.
    Sawanobori E; Hung WC; Takano T; Hachuda K; Horiuchi T; Higuchi W; Hung WW; Iwao Y; Nishiyama A; Reva I; Reva G; Teng LJ; Yamamoto T
    J Microbiol Immunol Infect; 2015 Oct; 48(5):565-73. PubMed ID: 25070278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comment on: linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
    De Beeck VO; Dhif N; Philipp J; De Bels D
    J Antimicrob Chemother; 2006 Mar; 57(3):577. PubMed ID: 16431858
    [No Abstract]   [Full Text] [Related]  

  • 38. No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
    Wegner DL
    MLO Med Lab Obs; 2005 Jan; 37(1):26-9. PubMed ID: 15743145
    [No Abstract]   [Full Text] [Related]  

  • 39. Panton-Valentine leukocidin-producing Staphylococcus aureus necrotising pneumonia: measuring toxin levels in microbiological samples to attest of linezolid clinical efficacy.
    Pasquier P; Muller V; Villevieille T; Rousseau JM; Janvier F; Etienne J
    Int J Antimicrob Agents; 2010 Jun; 35(6):613-4. PubMed ID: 20206478
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical, epidemiological, and laboratory aspects of methicillin-resistant Staphylococcus aureus (MRSA) infections.
    Palavecino E
    Methods Mol Biol; 2007; 391():1-19. PubMed ID: 18025665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.